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While approximately half of all qualified hospital pharmacist independent prescribers (PIPs) in Scotland
are active prescribers, there are major differences in prescribing activity across geographical areas. This
study aimed to explore, through focus groups, interviews and a questionnaire, hospital PIPs' perceptions
of factors associated with prescribing activity and to investigate the infrastructure required to better
support active prescribing by PIPs. Findings reinforced the perceived positive impact of supportive
pharmacy leadership within the organisation, recognition that prescribing is integral to the clinical
pharmacist role and a work environment conducive to prescribing.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prescribing by non-medical health professionals (non-medical
prescribing) is now established in a wide range of countries
including Australia, Canada, Finland, Ireland, Jamaica, New Zealand,
South Africa, Spain, Sweden, The Netherlands, United Kingdom
(UK) & the United States of America.1 Internationally, different
models of pharmacist prescribing exist with some countries
allowing non-medical prescribers (NMPs) to prescribe on an in-
dependent basis e.g. UK, Canada, Ireland and New Zealand and
some allowing NMPs to prescribe only under the supervision of a
doctor e.g. Australia.1,2
In 2003, UK legislation enabled pharmacists to practise as sup-
plementary prescribers using a condition specific treatment plan
agreed with an independent prescriber (doctor) and patient. In
2006, this extended to independent prescribing, defined as ‘pre-
scribing by a practitioner responsible and accountable for the
assessment of patients with undiagnosed or diagnosed conditions
and for decisions about the clinical management required,
including prescribing.’3,4 Independent prescribing courses in the
UK comprise university based and experiential learning mentored
by a medical practitioner who assesses competence in prescribing
and clinical activities. Currently there are over 19,000 nurse anduk (J. Fisher), moira.kinnear@
d@nes.scot.uk (F. Reid),
uk (D. Stewart).
Inc. This is an open access article u3000 pharmacist NMPs registered in the UK equating to 7% of the
pharmacist workforce.5,6 Nearly two-thirds (61%) of pharmacist
prescribers in the UK work in hospital.5
Service evaluations have reported quality improvements
following introduction of pharmacist prescribing including: opti-
misation of medicines7,8; reduced admissions and length of in-
patient stay9; reduced delays in hospital discharge9 and freeing
up medical time.10 In the UK, improved patient care and profes-
sional development are reported reasons for becoming a pharma-
cist independent prescriber (PIP).11 Initially medical colleagues
raised concerns about pharmacists taking on prescribing re-
sponsibilities due to pharmacists' limited diagnostic skills however
these issues appear to have resolved over time and many PIPs are
now integrated into the multidisciplinary team.12
While most published literature on pharmacist prescribing de-
scribes primary care management of chronic conditions such as
hypertension and secondary prevention in stroke,13,14 there is
potential to impact patient care and safety in hospital settings.
Studies of prescribing errors by medical staff cite error preva-
lence at around 7e9% of prescriptions written.15e17 While there are
limited data, one study of pharmacist prescribing in hospitals in
England reported error prevalence of 0.3% of prescriptions writ-
ten.18 The scope of pharmacist prescribing in hospital is developing
continually. Hospital pharmacists prescribe in a diverse range of
clinical specialities including acute medicine, antimicrobials, car-
diology, diabetes, hypertension, mental health, neurology, pain
management, oncology, orthopaedics and respiratory.5,19
The Scottish Government strategy, ‘Prescription for Excelle-nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(NHS) pharmaceutical care in Scotland will be accredited ‘clinical
pharmacist independent prescribers’ by 2023.20 To achieve this
vision, there is a need to ensure all qualified prescribers are
active. In 2012/13 approximately half of all qualified hospital PIPs
in NHS Scotland (147/274) were actively prescribing with varia-
tions in prescribing activity between NHS Boards (unpublished
work).
A further study found that pharmacists' adoption of prescribing
was dependent on ‘the pharmacist, system readiness, communi-
cation and influence (management).’21 However this study did not
examine the infrastructure required to support hospital pharmacist
prescribing. A Canadian study suggested that certain personality
traits of some pharmacists (e.g. lack of clinical confidence, fear of
new responsibility and associated clinical risks) may not link with
prescribing activities.22
However, a lack of support (financial and time resources),
medical staff acceptance and the pharmacy profession itself
(adoption, implementation strategy, resources and second phar-
macist clinical check) have been listed as barriers to non-medical
prescribing, not only in UK but further afield.2,19 A survey in the
North of England identified potential solutions to some of these
barriers which included addressing funding issues and the devel-
opment of a prescribing framework but this was a small regional
project and did not investigate the infrastructure required to sup-
port hospital PIPs at a national level.12
Potential barriers preventing pharmacists from actively pre-
scribing need to be investigated so they can be addressed and the
appropriate actions taken to help ensure widescale implem-
entation.
This study aimed to determine and explore hospital PIPs per-
ceptions of factors and behavioural determinants associated with
prescribing activity and to investigate the infrastructure required to
better support active prescribing by PIPs in NHS hospitals across
Scotland.
2. Methods
2.1. Design
This was a mixed methods, exploratory sequential study
comprising qualitative methods through focus groups and semi-
structured interviews to try and obtain in-depth thoughts and
opinions from NHS Boards that informed best practice followed by
a cross-sectional survey.
2.2. Setting
The research was conducted within all 14 health boards of NHS
Scotland.
2.3. Phase 1: focus groups and 1:1 semi-structured interviews
2.3.1. Inclusion criteria
All active PIPs (n ¼ 65) in the top 3 NHS Boards (in terms of the
proportion of qualified PIPs actively prescribing) and pharmacy
managers from each of these 3 NHS Boards were included in the
study, with no exclusions.
2.3.2. Sample size & recruitment
The Scottish Government provides funding through NHS Edu-
cation for Scotland (NES) to support the training of NHS employed
pharmacists. NHS Education for Scotland manage a pharmacist
prescriber database of PIPs (qualified, in-training & registered for a
prescribing course) in NHS Scotland. Their prescribing status(active or inactive) and the area in which they prescribe (commu-
nity pharmacy, primary care or secondary care) is updated annually
from each of the 14 NHS Boards, training universities and NES
funding data.
Contact information held within the NES database was used to
invite participation via email, which also included participant in-
formation. Of those responding to the email, a convenience sample
of PIPs (n ¼ 25) determined by availability, from a range of speci-
alities, were recruited to hospital-based focus groups and, for
logistical reasons, the 3 managers participated in 1:1 semi-
structured interviews (2 face-to-face and 1 telephone interview
due to manager preference).
2.3.3. Data generation
The study team drew on the experience within the team, which
included the national lead for pharmacist prescribing and an
experienced PIP, and agreed the focus group prompts and interview
schedule, following review of the literature.1e3,11,12 Focus groups
are used to explore participants views and experiences, identify
their concerns and priorities and the interaction between the group
can stimulate discussion which can generate new ideas and give
greater depth to the discussion.23 They can be less time consuming
than interviews with the same number of participants however
they can be less useful at examining the thoughts and reasoning of
individuals in detail23 and not all participants will comment on all
questions. The focus groups were led by the main investigator with
another member of the project team acting as a facilitator, taking
notes. The main investigator conducted the 3 interviews. The in-
terviewswere semi-structured 1:1 interviews as it was thought this
would provide opinions without losing focus. Interviews allow
ambiguous responses to be clarified and further questioning about
a particular issue raised can take place to give a more detailed
response if necessary. Topics for both the focus groups and in-
terviews included departmental infrastructure, pharmacy and
multidisciplinary team support and attitudes to prescribing (see
Appendix 1). Written consent was obtained from all the partici-
pants prior to participation and all discussions were recorded
digitally. Recordings were transcribed verbatim and a sample (25%)
checked for reliability of transcribing by a pharmacy administrator.
2.3.4. Analysis
Using theory to help understand the action of intervention
strategies to change behaviour(s) has been shown to improve the
effectiveness of intervention(s).24 The Theoretical Domains
Framework (TDF) was used in this study as a coding framework in
analysis of the qualitative data. The TDF draws together, from 33
theories of behaviour, the crucial influences on behaviour and
consists of 14 domains (Table 1) e.g. knowledge, skill, professional
role and identity and environmental context and resources.25 TDF
was used to provide headings to code the transcripts which were
then analysed independently by members of the study team using
the Framework Approach. This is a systematic method of catego-
rising large amounts of qualitative data and identifies ‘commonal-
ities and differences in qualitative data, before focusing on
relationships between different parts of the data, thereby seeking
to draw descriptive and/or explanatory conclusions clustered
around themes.’26
In reporting the results from the focus groups and interviews
each PIP was designated a number and a letter denoting the hos-
pital site, for example, PIP 1A. Each manager who participated in
the 1:1 interviews was designated a number, for example, M1.
2.4. Phase 2: cross-sectional survey
An on-line questionnaire was developed by constructing items
Table 1
Theoretical domains presented with a definition and sample construct.25
Domain Definition and example of construct
Knowledge An awareness of the existence of something e.g. procedural knowledge
Skill An ability or proficiency acquired through practice e.g. ability
Social/professional
role & identity
A coherent set of behaviours & displayed personal qualities of an individual in a social or work setting e.g. professional confidence
Beliefs about
capabilities
Acceptance of the truth, reality or validity about an ability, talent or facility that a person can put to constructive use e.g. self confidence
Optimism The confidence that things will happen for the best or that desired goals will be attained e.g. optimism, pessimism
Beliefs about
consequences
Acceptance of the truth, reality or validity about outcomes of a behaviour in a given situation e.g. outcome expectancies
Reinforcement Increasing the probability of a response by arranging a dependent relationship or contingency between the response and a given stimulus
e.g. rewards
Intentions A conscious decision to perform a behaviour or resolve to act in a certain way e.g. stability of intentions
Goals Mental representatives of outcomes or end states that an individual wants to achieve e.g. goal/target setting
Memory, attention
& decision processes
The ability to retain information, focus selectively on aspects of the environment & choose between two or more alternatives e.g. decision
making
Environmental context
& resources
Any circumstances of a person's situation or environment that discourages or encourages the development of skills and abilities,
independence, social competence and adaptive behaviour e.g. resources
Social influences Those interpersonal processes that can cause individuals to change their thoughts, feelings or behaviours e.g. social pressure
Emotion A complex reaction pattern, involving experiential, behavioural and physiological elements, by which the individual attempts to deal with a
personally significant matter or event e.g. anxiety
Behavioural regulation Anything aimed at managing or changing objectively observed or measured actions e.g. action planning
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with reference to TDF. 5 PIPs, selected from 2 local hospitals who
were working in different clinical specialities (2 active and 3 inac-
tive prescribers), reviewed the questionnaire for face and content
validity and piloted the functionality of the online mode of delivery.
Minor amendments (rewording of two questions to remove am-
biguity and one grammatical change) were made to the format.
The questionnaire contained 5 main sections: consideration of
local pharmacy services before applying for the prescribing course
(5 questions); work place support during the PLP1 (period of
learning in practice) (5 questions); implementation of prescribing -
active PIPs only (3 questions); reasons for activity and inactivity (2
questions) and education and training opportunities for PIPs in NHS
Scotland (3 questions). The questionnaire contained a variety of
question types with the majority of questions based on a 5- point
Likert scale (‘strongly agree’, ‘agree’, ‘neither agree/disagree’,
‘disagree’ and ‘strongly disagree). Some closed questions and
multiple choice questions (with the allowance of more than one
answer & free text comments) were also included in the
questionnaire.
2.4.1. Inclusion criteria
All hospital PIPs (including the 5 PIPs who participated in the
pilot) in NHS Scotland (n¼ 274) were included in the study, with no
exclusions.
2.4.2. Data collection
The questionnaire, formatted in Survey Monkey®, was distrib-
uted via email (containing study information & deadline for
completion). Participants were asked to complete the question-
naire within 2 weeks and 2 reminder emails were sent 1 week
apart.
2.4.3. Analysis
Data was analysed using descriptive statistics. Chi square was
used to test for association between variables, for example, per-
ceptions of prescribing being integral to the role of the pharmacist.
Strongly agree and agree were combined, as were strongly disagree
and disagree. P-values < 0.05 were considered statistically
significant.1 PLP is 90 hours of learning in practice mentored by a medical practioner.2.4.4. Research ethics
NHS Research Ethics Committee approval was not necessary as
the study involved NHS employees only. Approval was granted
from NHS Scotland Directors of Pharmacy.3. Results
3.1. Phase 1
29 PIPs agreed to participate in focus groups, with 25 PIPs
selected based on availability. Each focus group lasted approxi-
mately 50 min. The demographics of the participants are outlined
in Table 2. The participants prescribed in awide range of specialities
e.g. respiratory, surgery, cardiology, mental health, rheumatology
and acute medicine.
The key themes identified in the focus groups and interviews
mapped to the TDF are described in Table 3.3.1.1. Knowledge
a) Appropriate knowledge to prescribe
All PIPs felt they had the appropriate knowledge to prescribe
and were the most appropriate healthcare professionals for this
task.
‘We have for years come up with prescribing regimes for someone
else with less clinical knowledge to sign the bottom and take re-
sponsibility and that always felt very wrong for any of us so to take
that on was a positive thing.’ (PIP 5D)
Active PIPs were aware of their prescribing limitations and
identified areas in which they lacked competence hence would not
prescribe:
‘There are some things they (nurses) kind of think because you're a
prescriber you will prescribe the fluids. No chance.’ (PIP 2C)
3.1.2. Beliefs about capabilities
a) Competence
Table 2
Demographics of focus group participants.
Participant Length of time
practicing as a prescriber
Frequency of
prescribing in
clinical practice
Hospital 1
A 6 years Daily
B >5 years 3-5 times/week
C 6 months Daily
Hospital 2
A 4 years Daily
B 5 years Daily
C 5 years Daily
D 2 years Daily
E 3 years Daily
Hospital 3
A 7 years Daily
B 14 months Daily
C 4 years Daily
Hospital 4
A 3.5 years Daily
B >5 years Daily
C 2-3 years Daily
D 5-6 years Daily
Hospital 5
A 7 years Daily
B 1.5 yrs Daily
C 6 years Weekly
D 1.5 yrs Weekly
E 7 years Daily
F 4 years Daily
G 4 years Daily
H 6 years Daily
I 3 months 3-5 times/week
J 3 years 3-5 times/week
K 5 years Weekly
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was more appropriate for them to prescribe rather than recom-
mend prescribing by a doctor who may be acting out-with their
competence:
‘The doctor would sign whatever you wanted them to so they were
taking responsibility for your decisions which is completely unfair
so it's more about us being competent and taking responsibility for
it.’ (PIP 1C)
b) Professional confidence
All PIPs reported that confidence developed over time and as
more colleagues took on the prescribing role:Table 3
Key themes identified in the focus groups& 1:1 interviewsmapped to TDF domains.
TDF domains Themes
Knowledge a) Appropriate knowledge to prescribe
Beliefs about capabilities a) Competence
b) Professional confidence
Environmental context & resources a) Size of NHS Board
b) Organisational culture
c) Pharmacy management support
d) Multi-disciplinary (MDT) support
e) Defined career pathway
Social influences a) Peer support
b) MDT support
c) Nurse NMPs
d) Motivation
Professional role & identity a) Experts in medicines
b) Professional development
c) Integration with MDT
Beliefs about consequences a) Improved efficiency
b) Deskilling of junior doctors‘I think once one of you starts in the department there's the con-
fidence that you can do it there are no issues.’ (PIP 4A)
One manager highlighted, when pharmacist prescribing was
first introduced, PIPs were concerned that there was no profes-
sional check carried out by a second pharmacist on discharge
prescriptions, but this was no longer a concern as the PIPs gained
confidence and experience:
‘That was something that there was a lot of concern about (having
a second check) but I think that we have moved on now they have
more experience.’ (M1)
3.1.3. Environmental context & resources
a) Size of NHS board
The NHS Boards participating in the focus groups were 3 of the
smaller NHS Boards in NHS Scotland. Some PIPs recognised that the
smaller number of staff facilitated good working relationships with
the MDT:
‘We are a smaller health-board & we work with a smaller group of
consultants so you build up better relationships.’ (PIP 1B)
The PIPs also commented that working in a smaller NHS Board
made it easier to implement a new service (i.e. prescribing) as there
were fewer management processes required:
‘I think it's the joy of a smaller Board that things can be approved
within the ADTC (Area Drug & Therapeutics Committee) quicker,
there are less people involved.’ (PIP 5H)
b) Organisational culture
Managers ensured they were engaged with the prescribing
plans of their pharmacists and expected their pharmacists to
prescribe:
‘As part of work force planning we look at what we can offer to the
team to make the pharmacist role as successful as possible …. the
expectation is that they would be prescribers.’ (M1)
c) Pharmacy management support
All PIPs felt well supported by pharmacy management during
the course, ‘there was definitely the overall support to actually become
a prescriber’ (PIP 3B) and were given time to attend ward rounds/
clinics as part of their PLP:
‘they are given support to attend clinics and ward rounds that they
wouldn't normally do …..so they can gather the hours for the PLP.’
(M2)
d) MDT support
Although 1 PIP encountered resistance from a consultant when
she first began to prescribe, after building a relationship with them,
there was ‘now no resistance what-so-ever’ (PIP 4C). All the other
PIPs felt well supported by their consultants:
‘The consultants were all very supportive and in terms of winning
over some of the registrars and junior doctors I think the atten-
dance on ward rounds was probably the best benefit.’ (PIP 3A)
e) Defined career pathway
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was a definite career path at their hospitals:
‘The culture is such that you do your stage 2 (vocational training
program in NHS Scotland for junior pharmacists), you do your
diploma (post-graduate diploma in clinical pharmacy), you do
your prescribing, it's a very structured progression.’ (PIP - 5H)
3.1.4. Social influences
a) Peer support
All PIPs agreed that peer support was essential when
completing the PLP:
‘I think peer support is the biggest thing. That has been the biggest
help.’ (PIP 2C)
Managers encouraged those who had qualified recently as pre-
scribers to mentor those commencing the course:
‘We encourage who did the course last to try and have some input
for the others doing it next so they are actually getting up-to-date
information about how they manage the diary (completed during
the PLP) and how they present the evidence.’ (M2)
d) MDT support
All PIPs reported that having established relationships with
their MDT helped to provide a supportive environment:
‘We are quite a stable work force in that the folk that are here have
been here for a long time and they (doctors) get confidence in you
and you feel a bit more supported.’ (PIP 1A)
c) Nurse NMPs
Some PIPs suggested that seeing the progression of nurse pre-
scribers had encouraged them to become NMPs:
‘I think it's maybe a case of well if the nurse can prescribe why can't
we prescribe?’ (PIP 1B)
d) Motivation
All PIPs were motivated to start prescribing once they got the
qualification and a manager suggested that once colleagues started
to prescribe it had a knock-on effect for others:
‘I suppose success breeds success.’ (M2)
3.1.5. Professional role & identity
a) Experts in medicines
All the participants considered themselves to be the experts in
medicines andwould take responsibility for prescribing rather than
giving the responsibility to a junior doctor who may not be
knowledgeable about the medicine:
‘If I'm asking them (junior doctors) not to follow the policy (for
prescribing a particular medicine) then I should take responsibility
for that. It's my area of expertise so it's more to do with expertise
and knowledge.’ (PIP 4B)
b) Professional developmentAll PIPs thought prescribing was the next step to progress the
future of pharmacy and if pharmacists did not embrace prescribing,
other healthcare professionals would step in and prescribe in the
future:
‘Prescribing has to be one of the mechanisms to drive the future of
our profession so it's really important that … …we find groups of
patients we can prescribe in and basically be seen as a useful
member of theMDTor the role will be taken by others…. we are the
ideal candidates to be doing that.’ (PIP 3A)
c) Integration with MDT
All PIPs highlighted several benefits of their prescribing role
including increased integration, ‘I feel like I'm more integrated with
the consultant's team.’ (PIP 3B) and respect in the MDT:
‘I think they respect your clinical opinion more.’ (PIP 4A)
3.1.6. Beliefs about consequences
a) Improved efficiency
Some PIPs described working more efficiently as prescribers
with less time spent contacting junior doctors to make changes to
medicines:
‘The driving force to become a prescriber was to try and improve
efficiencies in the job rather than having to chase a junior doctor to
prescribe something that I could prescribe myself.’ (PIP 3A)
b) Deskilling of junior doctors
All the PIPs refuted the concerns that junior doctors would be
deskilled as a result of pharmacist prescribing:
‘ … the other advantage of prescribing is that you are a good
mentor to the junior doctors. The person that is going to be best at
prescribing is the pharmacist and people can see how it is done
properly then you're more likely to have a better skilled team.’ (PIP
5B)
Some PIPs commented that when they did prescribe, amend or
discontinue medicines they usually spoke to the junior doctor so
the doctor could learn from this:
‘I do tend to go and have a chat with the junior doctor about it but
also when I discontinue or start something so they can learn from
this.’ (PIP 3A)
3.2. Phase 2
The questionnaire was emailed to all 274 hospital PIPs across
NHS Scotland. There were 183 responses, 13 of which were
incomplete and excluded from the analysis. The response rate was
62% (170/274).
Seventy six percent of responders (130/170) were actively pre-
scribing at the time of the study. Sixty seven percent (130/195) of all
active hospital PIPs and 51% (40/79) of all inactive hospital PIPs
across NHS Scotland responded. It was noted that these figures
showed a higher proportion of active hospital PIPs compared to the
beginning of the study when approximately half of all qualified
hospital PIPs in NHS Scotland (147/274) were actively prescribing.
This could be explained by more hospital PIPs becoming active
prescribers between the time the study was initiated and sending
Table 4
Demographic information of respondents to questionnaire.
Demographic Active PIPs
(n ¼ 130)
Inactive PIPs
(n ¼ 40)
Number of years, mean ± SD (range)
- registered as a pharmacist 19.3 ± 7.8 (6e42) 19.3 ± 8.1 (7e37)
- qualified as a PIP 4.6 ± 3.1 (0.5e14) 5.7 ± 3.3 (0.5e10)
Qualification, n (%)
- supplementary prescriber (n ¼ 12) 2 (17%) 10 (83%)
- independent prescriber (n ¼ 158) 128 (81%) 30 (19%)
Work place, n (%)
- large teaching hospital (n ¼ 84) 68 (81%) 16 (19%)
- district general hospital (n ¼ 65) 51 (78%) 14 (22%)
- other e.g. specialist
oncology centre (n ¼ 21)
11 (52%) 10 (48%)
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the NES database, where the figures were obtained from, is that it is
continually updated throughout the year with self-reported data by
pharmacist prescribers.
The demographic information of the respondents is summar-
ised in Table 4.
The results from the Likert scale statements in the questionnaire
are outlined in Table 5. For each statement, the active prescribers'
responses are stated in the top line and the inactive prescribers'
responses stated in the bottom line. The major findings from the
questionnaire were that active PIPs were more likely than inactive
PIPs to consider prescribing integral to their role as a pharmacist;
75.4% v 37.5%, p < 0.0001. Active PIPs were also more likely than
inactive PIPs to have a clear prescribing role agreed with their line
manager prior to commencing the course; 65.4% v 45%, p< 0.05 and
felt better supported by pharmacy management (72.4% v 47.5%),
p < 0.01 and the multi-disciplinary team (90% v 72.5%), p < 0.05.
The reasons given by inactive PIPs for not prescribing are out-
lined in Table 6.
15 PIPs stated that backfill of their substantive post was the
reason for not prescribing. Of those 15 PIPs, 6 had haematology
and/or oncology roles which follow the Scottish Government's
‘Guidance for the safe delivery of systemic anticancer (SACT)’ that
all prescriptions for SACT should be clinically checked by a suitably
trained pharmacist.27 This is interpreted as requiring a second
pharmacist to check the prescription therefore if a PIP had pre-
scribed chemotherapy then another pharmacist is required to
check the prescription which can be difficult depending on the
capacity of the oncology/haematology pharmacist workforce. The
remaining 9 PIPs worked in a variety of specialities, for example,
respiratory, cardiology, acute medicine and surgery where no
‘second check’ is required hence it is unclear as to why these
pharmacists thought backfill of their substantive post was required
before they could prescribe.
Other reasons for not prescribing described in free text com-
ments in the questionnaire included:
‘I am present for 2e3 hours a day on the ward & feel I cannot
commit to taking on a role that is only provided in a limited time
frame.’ (Inactive PIP e NHS Board 3)
‘I work part-time and feel that time is a huge obstacle to me pre-
scribing.’ (Inactive PIP e NHS Board 6).
‘Even having time released for lunch is a challenge.’ (Inactive PIP e
NHS Board 7)
4. Discussion
4.1. Key findings
The findings have provided valuable information to help un-
derstand the factors which may influence pharmacists to prescribe.
‘Environmental context & resources’, particularly organisational
culture, appeared to influence PIPs prescribing. ‘Social influences’
including peer, management & MDT support, also resulted in pre-
scribing activity. ‘Professional role and identity’ were also influen-
tial with all active PIPs considering prescribing integral to their role
as clinical pharmacists.
Findings from the questionnaire suggest that, in agreement with
the focus groups, active PIPs were more likely to consider pre-
scribing as integral to their role as a pharmacist (p < 0.0001). Active
PIPs were also more likely to have a clear prescribing role agreed
with their line manager (p < 0.05) and felt better supported by
pharmacy management (p < 0.01) and the MDT (p < 0.05) thaninactive PIPs. Backfill of substantive posts was the most common
reason given by PIPs for not prescribing but further work is required
to explore perceptions of this barrier to prescribing.4.2. Interpretation of results
Environmental context & resources appeared to influence pre-
scribing particularly organisational culture in the workplace where
the expectation from the pharmacy managers in the high pre-
scribing activity NHS Boards is that all qualified PIPs prescribe. For
sustained organisational change, there may be a need to address
interdisciplinary behaviours and leadership among the prescribing
professions. With the increasing pressures on healthcare resources
it is essential to ensure there is efficient staffing models involved in
planning of the hospital workforce. Hospitals are an ideal setting for
pharmacists to prescribe as they have easy access to medical re-
cords and laboratory results. By widely implementing pharmacists'
prescribing, improvements would be made to patient safety and
there would also be improved professional satisfaction. It is
essential that pharmacists have a clear prescribing role identified
and agreed with pharmacy management prior to applying for
prescribing courses. Targeted activities have more chance of being
executed and becoming reality if there is a clear shared vision.
Social influences including peer, management & MDT support
also resulted in prescribing activity. Active prescribers were more
likely to have felt better supported by pharmacy managers during
their PLP than those not prescribing (p < 0.01). This was in agree-
ment with other studies which stated that pharmacists ‘recognised
the need and expressed desire’ to have management support to
take prescribing forward.12,21 Pharmacy managers set and promote
the culture towards education and training in their hospitals and
act as role models for colleagues. Their leadership in establishing
direction, motivating and supporting their staff are all important
both during the PLP and for future service delivery.
Although there was no statistically significant difference be-
tween the active and inactive PIPs in terms of local pharmacy peer
support being available during implementation of prescribing,
there was a trend to suggest that those prescribing perceived there
to have been good peer support compared to those not prescribing.
There were similar conclusions in previous studies which found
that pharmacists who networked with other colleagues and net-
works had more active prescribing practices.12,21
Active PIPs were more likely to have felt well supported by the
MDT during their PLP than those not prescribing (p < 0.05). It is
important that there is support from the MDT during the PLP to
ensure successful implementation of prescribing.12,19,21 In a previ-
ous study pharmacists acknowledged that team member support
was crucial to their prescribing success and the physician-
prescriber relationship was often a primary consideration for
pharmacists deciding to prescribe.21 Pharmacists expressed a
Table 5
Responses to statements in questionnaire.
Statement (n ¼ 130 active) (n ¼ 40
inactive)
Strongly
agree n(%)
Agree n(%) Neither agree or
disagree n(%)
Disagree n(%) Strongly
disagree n(%)
p value
(chi square)
Sustainability of existing prescribing
pharmacy services is considered
locally before supporting applicants
for the prescribing course.
4
(3.1)
44
(33.8)
54
(41.5)
27
(20.8)
1
(0.8)
0.51
3
(7.5)
9
(22.5)
16
(40)
10
(25)
2
(5)
Service redesign of existing pharmacy
services is considered locally before
supporting applicants for the
prescribing course.
1
(0.8)
32
(24.6)
53
(40.8)
41
(31.5)
3
(2.2)
0.19
1
(2.5)
4
(10)
17
(42.5)
15
(37.5)
3
(7.5)
Prescribing in secondary care is
integral to the clinical pharmacist
role.
37
(28.5)
61
(46.9)
18
(13.8)
14
(10.8)
0
(0)
<0.0001
3
(7.5)
12
(30)
12
(30)
10
(25)
3
(7.5)
There is a structured career progression
pathway in my hospital that all
pharmacists are expected to follow
e.g. complete stage 2 training, MSc,
independent prescribing.
35
(26.9)
56
(43.1)
18
(13.9)
18
(13.9)
3
(2.2)
0.58
5
(12.5)
22
(55)
4
(10)
8
(20)
1
(2.5)
Before I applied for the course I had a
clear prescribing role agreed with
my line manager.
30
(23.1)
55
(42.3)
14
(10.8)
27
(20.8)
4
(3)
<0.05
7
(17.5)
11
(27.5)
11
(27.5)
7
(17.5)
4
(10)
During the PLP I was well supported
by pharmacy management to meet
my identified learning needs e.g.
attend ward rounds and/or clinics.
34
(26.2)
60
(46.2)
18
(13.8)
16
(12.3)
2
(1.5)
<0.01
7
(17.5)
12
(30)
8
(20)
12
(30)
1
(2.5)
There was good local pharmacy peer
support during the PLP in my
hospital.
15
(11.5)
57
(43.9)
30
(23.1)
25
(19.2)
3
(2.3)
0.28
2
(5)
19
(47.5)
6
(15)
10
(25)
3
(7.5)
I felt well supported by the MDT
during my PLP.
53
(40.8)
64
(49.2)
12
(9.2)
1
(0.8)
0
(0)
<0.05
12
(30)
17
(42.5)
11
(27.5)
0
(0)
0
(0)
On reflection the activities I completed
during my PLP were relevant to my
area of prescribing practice at the
time of qualification.
43
(33.1)
81
(62.3)
3
(2.3)
1
(0.8)
2
(1.5)
0.081
14
(35)
20
(50)
3
(7.5)
3
(7.5)
0
(0)
There are regular opportunities at my
hospital to discuss non-medical
prescribing issues.
7
(5.4)
53
(40.8)
32
(24.6)
35
(26.9)
3
(2.3)
0.07
2
(5)
10
(25)
17
(42.5)
9
(22.5)
2
(5)
There was good local pharmacy peer
support during implementation of
prescribing in my hospital.
8
(6.2)
52
(40)
40
(30.7)
27
(20.8)
3
(2.3)
0.055
1
(2.5)
10
(25)
13
(32.5)
11
(27.5)
5
(12.5)
There is good national support via
specialist pharmacy networks for
implementing prescribing in my
scope of practice.
2
(1.5)
44
(33.9)
52
(40)
30
(23.1)
2
(1.5)
0.71
5
(12.5)
12
(30)
14
(35)
8
(20)
1
(2.5)
When I qualified I had a clear idea of my
scope of prescribing practice.
33
(25.4)
75
(57.7)
12
(9.2)
8
(6.2)
2
(1.5)
0.48
6
(15)
27
(67.5)
2
(5)
5
(12.5)
0
(0)
Non-medical prescribing deskills junior
doctors.
2
(1.5)
21
(16.2)
28
(21.5)
62
(47.7)
17
(13.1)
0.12
1
(2.5)
9
(22.5)
13
(32.5)
11
(27.5)
6
(15)
Seeing the development of other
NMPs has made me want to
prescribe.
14
(10.8)
51
(39.2)
52
(40)
12
(9.2)
1
(0.8)
<0.05
4
(10)
18
(45)
9
(22.5)
9
(22.5)
0
(0)
Statistically significant results are shown in bold in Table 5.
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supportive of pharmacist prescribing but this was not evident from
our study. This previous study also found that in the hospital or
ambulatory clinic setting, some pharmacists did not feel there was
a need to prescribe themselves as they were well integrated into
inter-professional teams where they had sufficient input onprescribing decisions.21 Therewas no evidence of this being a factor
contributing to inactivity in our study.
Professional role and identity were also influential. The active
PIPs were more likely to agree that prescribing in secondary care is
integral to the clinical pharmacist's role than those not actively
prescribing (p < 0.0001) and this is in agreement with an earlier
Table 6
Reasons given by inactive PIPs for not prescribing (respondents could select more
than one reason).
Reason for inactivity Responses from inactive
PIPs (n ¼ 40)
Backfill of substantive post 15
Moved job and yet to establish role 10
Moved job to non-patient facing role 8
Recently qualified & awaiting
NMP number*
4
Lack of pharmacy peer support 5
Lack of pharmacy
management support
5
Lack of MDT support 3
Lack of confidence 3
Other reason(s) 12
Total 65
* In NHS Scotland a NMP registration number (obtained from the NHS Board that
employs the PIP) is required before a qualified PIP can prescribe.
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perhaps more likely to consider it important for pharmacists to
extend their role which may include taking on prescribing activ-
ities. This outcome suggests there is a need to align NHS pharma-
cists to the Scottish Government's vision that all pharmacists
providing NHS pharmaceutical care will be accredited ‘clinical
pharmacist independent prescribers’ by 2023.20 Leadership will be
required to motivate and inspire people to want to achieve the
vision.
Lack of backfill of substantive posts was the most common
reason given by PIPs for not prescribing. Prior to funding for the
course, pharmacists must demonstrate a prescribing need in the
speciality they are working in. Apart from some specialist areas in
secondary care, for example in oncology, where in NHS Scotland
chemotherapy prescriptions have to be clinically checked by a
pharmacist,27 it is unclear why ‘backfill’ would be needed for other
PIPs based on wards who would be changing drug administration
charts and/or discharge prescriptions, rather than getting a junior
doctor to make these amendments. These issues regarding ‘backfill’
therefore require further exploration. If PIPs were organising
pharmacist-led clinics to meet a service need then backfill would
need to be considered including resource requirements. Current
austerity measures within healthcare settings requires redesign of
clinical pharmacy services to align activities to vision and policy
which incorporates more prescribing activities and removal of
other activities of less importance.
A pharmacist may have the prescribing qualification but lack the
specialist knowledge and confidence to prescribe as part of their
role and this has been highlighted previously as potential reasons
as to why not all qualified PIPs routinely prescribe.5,22,28 In this
study only 3/40 inactive PIPs stated that confidence was an issue
that contributed to inactivity with lack of specialist knowledge not
highlighted as a factor resulting in prescribing inactivity. Previous
studies highlighted that some pharmacists had concerns over the
risk and liability associated with prescribing which generally less-
ened with prescribing experience but there were no concerns
raised in this study.21,22 Having time to prescribe has been high-
lighted as another possible reason for inactivity but only 3/40
inactive PIPs in this study commented that a lack of time resulted in
not prescribing.12,19
4.3. Further research
Further qualitative work based on the TDF will be undertaken to
explore reasons for inactivity in greater depth so that a target be-
haviour(s) can be identified. Intervention(s) will subsequently bedesigned using the Behaviour Change Wheel to try and increase
prescribing activity.29
4.4. Study strengths and weaknesses
The mixed methods sequential design of this study was
considered appropriate to gather PIPs' in-depth reflections on
prescribing during qualitative enquiry and to quantify issues using
a survey based methodology. The use of qualitative data from the
focus groups to inform the design of the questionnaire ensured
maximum variability, removed investigator bias and assumption
and promoted content validity. The themes identified from the
focus groups were mapped to a validated framework (the TDF)
hence enhancing the robustness and rigour of the study.
Qualitative methods of data collection through sampling to
saturation may have been appropriate to achieve the study objec-
tives if a larger number of participants had been recruited. As only 3
NHS Boards took part in the focus groups and 1:1 interviews and
there was a 62% response rate to the questionnaire there was po-
tential recruitment and response biases which may reduce the
transferability of the qualitative data and the generalisability of the
quantitative data. The questionnaire results were based on self-
reported perceptions as opposed to observation of actual practice.
Another limitation is the potential non-representation of data as
only 67% and 51% of active and inactive PIPs respectively in NHS
Scotland responded to the questionnaire.
5. Recommendations and conclusions
Through organisational culture changes appropriate strategic
planning is required to influence prescribing activity. Continued
monitoring of prescribing activity of qualified PIPs will inform
progress in addressing changes as a result of organisational cultural
changes. Study findings indicate a continued need for pharmacy
management support to ensure prescribing activity by pharmacists
and a supportive work environment so that pharmacists perceive
prescribing as an integral part of their role. This shared vision can
become a reality if a clear prescribing role has been identified &
agreed with managers and multidisciplinary team members prior
to undertaking the prescribing qualification. In tandem with
agreement of a prescribing role, service re-designmay be necessary
to enable capacity for prescribing activity to succeed. Planning is
also necessary to enable staff undertaking their PLP to optimise
their learning opportunities to prepare them for the identified
prescribing role.
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Focus group questions.
1 Can you give briefly introduce yourself and outline your area of prescribing, length of prescribing & how often you prescribe?
2 Do you have any ideas why your health-board has a high uptake of active prescribers?
3 What were the driving factors for you applying for the course e.g. personal development plan, service requirements?
4 What support did you get for applying & attending the course & during your PLP (period of learning in practice)?
5 What activities did you do during your PLP that helped implementation?
6 Did you plan your PLP to meet service needs?
7 Was there any additional local training support during your IP training?
8 How did you implement prescribing into your practice e what worked well, not so well & how could it be improved?
9 What support did you receive for implementation e what was the attitude of local management?
10 What were the barriers that you had to overcome for implementation?
11 Is there a local independent prescribing plan/strategy available?
12 Are there local peer support and opportunities for continuing professional development available?
13 Has prescribing had an effect on your relationship within the multi-disciplinary team (MDT)?
14 Do you get feedback from your MDT on your role as a prescriber?
15 Do you get feedback from patients on your role as a prescriber?
16 From the discussions that we have had today is there anything else you would like to add or do you have any
s a high uptake of active prescribers?additional ideas as to why your health-board haTable B
1:1 interview questions for pharmacy managers.
1 Compared to other health-boards, there seems to be a high number of ‘active’ prescribers in your health-board e what do you think are the reasons for this?
2 Is there a local plan/strategy for implementation of pharmacist prescribing e what are the key elements, how was it developed and implemented?
3 Was the pharmacist prescribing implementation strategy developed alongside other non-medical prescribers' strategies?
4 Do you have a process for prioritising who should be trained e does this link to service redesign?
5 What support is given to pharmacists undertaking the course?
6 What support is given to pharmacists for implementing prescribing at your site?
7 How did you plan realigning other duties and responsibilities to allow for pharmacist prescribing implementation?
8 Are there perceived barriers to implementing pharmacist prescribing at your site? How have these barriers been overcome?
9 What are your plans for further developing the service?
10 If a pharmacist is not progressing with prescribing as expected what happens e are there systems in place for monitoring progress for individuals on the course?
11 Are there local peer review meetings for pharmacist prescribers?
12 Is it linked to individuals' personal development plans?References
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